High Levels of Expression of Activating Transcription Factor-2 (ATF2) Are Associated with Worse Prognosis in Patients with Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Liang, J. J.
Wang, H.
Bruggeman, R.
Evans, D. B.
Wang, H.
机构：
[1] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1609
引用
收藏
页码：362A / 362A
页数：1
相关论文
共 50 条
  • [1] High Levels of Expression of Activating Transcription Factor-2 (ATF2) Are Associated with Worse Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
    Liang, J. J.
    Wang, H.
    Bruggeman, R.
    Evans, D. B.
    Wang, H.
    LABORATORY INVESTIGATION, 2010, 90 : 362A - 362A
  • [2] High Levels of Expression of Activating Transcription Factor-2 (ATF2) Are Associated with High-Grade Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma
    Liang, J. J.
    Zhu, S.
    Li, W.
    Bruggeman, R.
    Han, B.
    MODERN PATHOLOGY, 2010, 23 : 362A - 362A
  • [3] High Levels of Expression of Activating Transcription Factor-2 (ATF2) Are Associated with High-Grade Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma
    Liang, J. J.
    Zhu, S.
    Li, W.
    Bruggeman, R.
    Han, B.
    LABORATORY INVESTIGATION, 2010, 90 : 362A - 362A
  • [4] The roles of ATF2 (activating transcription factor 2) in tumorigenesis
    Gozdecka, Malgorzata
    Breitwieser, Wolfgang
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 230 - 234
  • [5] Expression of Phosphorylated Activating Transcription factor 2 (ATF2) is associated with sensitivity to endocrine therapy in breast cancer
    Palmieri, C.
    Rudraraju, B.
    Abdel-Fatah, T. M. A.
    Moore, D. A.
    Shaw, J.
    Green, A.
    Ellis, O. I.
    Coombes, R. C.
    Simak, A.
    CANCER RESEARCH, 2012, 72
  • [6] ACTIVATING TRANSCRIPTION FACTOR ATF2 NEGATIVELY REGULATES THE EXPRESSION OF ENDOTHELIAL NOTCH LIGANDS
    Olivares, Ivonne
    Kalyanakrishnan, Krithika
    Ahmed, Suhail
    Murcott, Clare
    Wilkinson, Robert N.
    Cotton, James
    Breitwieser, Wolfgang
    Morris, Mark R.
    Armesilla, Angel L.
    HEART, 2019, 105 : A167 - A168
  • [7] Suppressor role of activating transcription factor 2 (ATF2) in skin cancer
    Bhoumik, Anindita
    Fichtman, Boris
    DeRossi, Charles
    Breitwieser, Wolfgang
    Kluger, Harriet M.
    Davis, Sean
    Subtil, Antonio
    Meltzer, Paul
    Krajewski, Stan
    Jones, Nic
    Ronai, Ze'ev
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) : 1674 - 1679
  • [8] Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
    Giannoudis, Athina
    Malki, Mohammed Imad
    Rudraraju, Bharath
    Mohhamed, Hisham
    Menon, Suraj
    Liloglou, Triantafillos
    Ali, Simak
    Carroll, Jason S.
    Palmieri, Carlo
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [9] Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
    Athina Giannoudis
    Mohammed Imad Malki
    Bharath Rudraraju
    Hisham Mohhamed
    Suraj Menon
    Triantafillos Liloglou
    Simak Ali
    Jason S. Carroll
    Carlo Palmieri
    Breast Cancer Research, 22
  • [10] Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2)
    Steinmüller, L
    Thiel, G
    BIOLOGICAL CHEMISTRY, 2003, 384 (04) : 667 - 672
12345